Bladder Cancer

Fuatilia
Illustration of a doctor delivering the gemcitabine-releasing bladder implant Inlexzo during a procedure, symbolizing successful tumor clearance in bladder cancer treatment.
Àwòrán tí AI ṣe

Gemcitabine-releasing bladder implant clears tumors in 82% of BCG‑unresponsive cases in phase 2 trial

Ti AI ṣe iroyin Àwòrán tí AI ṣe Ti ṣayẹwo fun ododo

A catheter-delivered implant that slowly releases gemcitabine eliminated visible tumors in 82% of patients with BCG‑unresponsive, high‑risk non‑muscle‑invasive bladder cancer in a phase 2 study. More than half of responders remained cancer‑free for at least a year, and the device has since been approved by the FDA as Inlexzo for patients with carcinoma in situ who are ineligible for, or decline, bladder removal.

The death certificate of 'The Middle' actor Pat Finn confirms bladder cancer as his cause of death, following initial reports of his passing on December 22, 2025, at age 60. Obtained by TMZ, the document details a years-long battle with a bladder tumor, with no other significant conditions listed.

Ojú-ìwé yìí nlo kuki

A nlo kuki fun itupalẹ lati mu ilọsiwaju wa. Ka ìlànà àṣírí wa fun alaye siwaju sii.
Kọ